Intensive care nurses' knowledge about use of neuromuscular blocking agents in patients with respiratory failure

American Journal of Critical Care

Volumn 24, Issue 5, 2015, Pages 431-440

  Frazee, Erin N ^a   Personett, Heather A ^a   Bauer, Seth R ^b   Dzierba, Amy L ^c   Stollings, Joanna L ^d   Ryder, Lindsay P ^e   Elmer, Jennifer L ^a   Caples, Sean M ^a   Daniels, Craig E ^a  

^a MAYO CLINIC   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^e THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROMUSCULAR BLOCKING AGENT;

CLINICAL COMPETENCE; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; DRUG MONITORING; HEALTH CARE SURVEY; HUMAN; INTENSIVE CARE; INTENSIVE CARE NURSING; MULTICENTER STUDY; PROCEDURES; PROSPECTIVE STUDY; RESPIRATORY DISTRESS SYNDROME, ADULT; STATISTICS AND NUMERICAL DATA;

CLINICAL COMPETENCE; CRITICAL CARE; CRITICAL CARE NURSING; CROSS-SECTIONAL STUDIES; DRUG MONITORING; HEALTH CARE SURVEYS; HUMANS; NEUROMUSCULAR BLOCKING AGENTS; PROSPECTIVE STUDIES; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 84941202267     PISSN: 10623264     EISSN: None     Source Type: Journal    
DOI: 10.4037/ajcc2015397     Document Type: Article

References (29)

1. Phillips MS, Williams RL. Improving the safety of neuromuscular blocking agents: a statement from the USP Safe Medication Use Expert Committee. Am J Health Syst Pharm. 2006;63(2):139-142.
2. Institute for Safe Medication Practices (ISMP). ISMP's List of High-Alert Medications in Acute Care Settings. 2012. http://www.ismp.org/tools/highalertmedications.pdf. Accessed May 21, 2015.
3. Murray MJ, Cowen J, DeBlock H, et al. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med. 2002;30(1):142-156.
4. Wagner BK, Zavotsky KE, Sweeney JB, Palmeri BA, Hammond JS. Patient recall of therapeutic paralysis in a surgical critical care unit. Pharmacotherapy. 1998;18(2):358-363.
5. Johnson KL, Cheung RB, Johnson SB, et al. Therapeutic paralysis of critically ill trauma patients: perceptions of patients and their family members. Am J Crit Care. 1999; 8(1):490-498.
6. Ballard N, Robley L, Barrett D, Fraser D, Mendoza I. Patients' recollections of therapeutic paralysis in the intensive care unit. Am J Crit Care. 2006;15(1):86-94; quiz 95.
7. Nelson BJ, Weinert CR, Bury CL, Marinelli WA, Gross CR. Intensive care unit drug use and subsequent quality of life in acute lung injury patients. Crit Care Med. 2000;28(11): 3626-3630.
8. Forel JM, Roch A, Marin V, et al. Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome. Crit Care Med. 2006;34(11):2749-2757.
9. Gainnier M, Roch A, Forel JM, et al. Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome. Crit Care Med. 2004;32(1):113-119.
10. Papazian L, Forel JM, Gacouin A, et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010;363(12):1107-1116.
11. Rubenfeld GD, Caldwell E, Peabody E, et al. Incidence and outcomes of acute lung injury. N Engl J Med. 2005;353(16): 1685-1693.
12. Hansen-Flaschen JH, Brazinsky S, Basile C, Lanken PN. Use of sedating drugs and neuromuscular blocking agents in patients requiring mechanical ventilation for respiratory failure: a national survey. JAMA. 1991;266(20):2870-2875.
13. Arroliga AC, Thompson BT, Ancukiewicz M, et al. Use of sedatives, opioids, and neuromuscular blocking agents in patients with acute lung injury and acute respiratory distress syndrome. Crit Care Med. 2008;36(4):1083-1088.
14. Loper KA, Butler S, Nessly M, Wild L. Paralyzed with pain: the need for education. Pain. 1989;37(3):315-316.
15. Foster JG, Kish SK, Keenan CH. A national survey of critical care nurses' practices related to administration of neuromuscular blocking agents. Am J Crit Care. 2001;10(3):139-145.
16. Arbour R. A continuous quality improvement approach to improving clinical practice in the areas of sedation, analgesia, and neuromuscular blockade. J Contin Educ Nurs. 2003;34(2):64-71; quiz 90-61.
17. Bair N, Bobek MB, Hoffman-Hogg L, et al. Introduction of sedative, analgesic, and neuromuscular blocking agent guidelines in a medical intensive care unit: physician and nurse adherence. Crit Care Med. 2000;28(3):707-713.
18. Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377-381.
19. Greenberg SB, Vender J. The use of neuromuscular blocking agents in the ICU: where are we now? Crit Care Med. 2013;41(5):1332-1344.
20. Rhoney DH, Murry KR. National survey of the use of sedating drugs, neuromuscular blocking agents, and reversal agents in the intensive care unit. J Intensive Care Med. 2003;18(3):139-145.
21. Barr J, Fraser GL, Puntillo K, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41(1):263-306.
22. The Joint Commission. Standard PC.01.02.07: The Hospital Assesses and Manages the Patient's Pain. In: Comprehensive Accreditation and Certification Manual. Oakbrook Terrace, IL: The joint Commission; 2014.
23. Jarpe MB. Nursing care of patients receiving long-term infusion of neuromuscular blocking agents. Crit Care Nurse. 1992;12(7):58-63.
24. Foster JG, Kish SK, Keenan CH. National practice with assessment and monitoring of neuromuscular blockade. Crit Care Nurs Q. 2002;25(2):27-40.
25. Wilson J, Collins AS, Rowan BO. Residual neuromuscular blockade in critical care. Crit Care Nurse. 2012;32(3):e1-9; quiz e10.
26. Rudis MI, Sikora CA, Angus E, et al. A prospective, randomized, controlled evaluation of peripheral nerve stimulation versus standard clinical dosing of neuromuscular blocking agents in critically ill patients. Crit Care Med. 1997;25(4):575-583.
27. Strange C, Vaughan L, Franklin C, Johnson J. Comparison of train-of-four and best clinical assessment during continuous paralysis. Am J Respir Crit Care Med. 1997;156(5):1556-1561.
28. Baumann MH, McAlpin BW, Brown K, et al. A prospective randomized comparison of train-of-four monitoring and clinical assessment during continuous ICU cisatracurium paralysis. Chest. 2004;126(4):1267-1273.
29. Lagneau F, D'Honneur G, Plaud B, et al. A comparison of two depths of prolonged neuromuscular blockade induced by cisatracurium in mechanically ventilated critically ill patients. Intensive Care Med. 2002;28(12):1735-1741.